mRNA and iPSC attract investments in July
PharmaDJ · 09/10/2021
Chinese drug developers continued to close more financing deals for the fourth consecutive month.
READ MORE
July Deal Numbers Slide After a Spike in June
Minhua Chu · 09/01/2021
China’s biotech industry saw a dip in deal volume and value for innovative drugs in July after a rebound in the previous month. Chinese biotech companies made a total of 10 deals, with disclosed deal value amounting to over $1.5 billion.
READ MORE
China Approves Two Innovative Cancer Drugs and Puts ...
Minhua Chu · 09/01/2021
China’s pursuit of innovative oncology drugs has kept Chinese regulators busy in July, as they granted the first marketing approvals to two foreign drugs and accepted NDAs for nine more new ones.
READ MORE
COVID-19 Vaccine Developers Attract Huge Investments...
Minhua Chu · 07/23/2021
China Biotech Fundraising Tracker: Jun 2021
READ MORE
June Numbers Spike with a Big In-Licensing Deal
Minhua Chu · 07/23/2021
China Licensing Deals Tracker: Jun 2021
READ MORE
China Market Approvals Surge in June
Minhua Chu · 07/23/2021
China Market Approval Tracker: Jun 2021
READ MORE
ADCs and Immuno-Oncology Therapies Attract Massive I...
Minhua Chu · 07/19/2021
China Biotech Fundraising Tracker: May 2021
READ MORE
China Licensing Deals Tracker: May 2021
Minhua Chu · 07/19/2021
LianBio Acquires Three Potential FIC Therapies for Cancer and IBD.
READ MORE
China Market Approval Tracker: May 2021
Minhua Chu · 07/19/2021
The NMPA Grants Three Orphan Drugs Market Approval.
READ MORE
READ MORE
Copyright © 2016-2021 PharmaDJ .All Rights Reserved.   Suggestions and feedback: Support@PharmaDJ.com   Record/License No.:沪ICP备17054709号-1  
About PharmaDJ | Subscription | Contact Us | Copyright Statement